The Alzheimer Disease Genetics Panel is a genetic test used to identify genetic mutations associated with an increased risk of developing Alzheimer's disease. The test examines specific genes such as APP, PSEN1, and PSEN2, which play a role in the development of the disease. This test is an important tool in assessing genetic risk, helping both doctors and patients make informed decisions regarding diagnosis and care. It also raises family awareness about the potential for developing the disease and facilitates appropriate future planning.